Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
4.880
+0.030 (0.62%)
Mar 26, 2026, 3:04 PM CST

SHE:300006 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
926.061,072836.44846.29559.43
Cash & Short-Term Investments
926.061,072836.44846.29559.43
Cash Growth
-13.62%28.18%-1.16%51.28%2.67%
Accounts Receivable
252.92286.67339.21348.39445.38
Other Receivables
149.15166.75268.73312.52539.13
Receivables
402.08453.42607.94660.9984.51
Inventory
161.33201.7171202.4157.77
Prepaid Expenses
-11.33.582.664.5
Other Current Assets
31.8731.5727.2133.2320.78
Total Current Assets
1,5211,7701,6461,7451,727
Property, Plant & Equipment
252.18274.92286.97339.92392.49
Long-Term Investments
384.12378.28519.68522.71481.36
Goodwill
44.9544.9532.9432.9432.94
Other Intangible Assets
131.18181.83189.3184.11116.36
Long-Term Accounts Receivable
--34.0632.41-
Long-Term Deferred Tax Assets
152.39128.24132.35116.58104.62
Long-Term Deferred Charges
55.5240.3627.2463.3762.53
Other Long-Term Assets
33.0437.1322.1517.649.47
Total Assets
2,5752,8562,8913,0552,927
Accounts Payable
93.4865.6237.949.6334.26
Accrued Expenses
37.8110.77107.55110.39109.24
Short-Term Debt
179.42242.91113.5121.5130
Current Portion of Long-Term Debt
135.4102.752458-
Current Portion of Leases
-3.654.2630.255.41
Current Income Taxes Payable
7.351.312.127.877.03
Current Unearned Revenue
13.2113.7917.8524.0413.07
Other Current Liabilities
261.82260.8255.09299.51317.8
Total Current Liabilities
728.49801.61562.27701.14666.8
Long-Term Debt
57.2141.45126.5149-
Long-Term Leases
1.463.832.536.5733.9
Long-Term Unearned Revenue
4.456.296.399.0412.26
Long-Term Deferred Tax Liabilities
19.0519.2919.264.471.68
Other Long-Term Liabilities
--51.76--
Total Liabilities
810.65972.47768.71870.22714.65
Common Stock
1,0561,0561,0561,0561,056
Additional Paid-In Capital
1,5071,4831,4831,4751,459
Retained Earnings
-750.67-501.33-414.9-406.22-358.52
Comprehensive Income & Other
-56.23-162.53-43.77--
Total Common Equity
1,7561,8752,0812,1242,156
Minority Interest
8.188.0441.5160.5255.78
Shareholders' Equity
1,7641,8832,1222,1852,212
Total Liabilities & Equity
2,5752,8562,8913,0552,927
Total Debt
373.48494.59270.79365.27219.32
Net Cash (Debt)
552.58577.51565.65481.02340.11
Net Cash Growth
-4.32%2.10%17.59%41.43%-
Net Cash Per Share
0.520.550.540.460.34
Filing Date Shares Outstanding
1,0561,0561,0561,0561,056
Total Common Shares Outstanding
1,0561,0561,0561,0561,056
Working Capital
792.85968.491,0841,0441,060
Book Value Per Share
1.661.781.972.012.04
Tangible Book Value
1,5801,6491,8581,9072,007
Tangible Book Value Per Share
1.501.561.761.811.90
Buildings
-411.75413.99412.67412.67
Machinery
-652.83646.2674.06664.11
Construction In Progress
-72.463.784.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.